Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromobox protein homolog 5 (CBX5), also known as HP1α, is a highly conserved, non-histone chromatin protein that functions as a key component of constitutive heterochromatin in eukaryotic cells[1][2][3]. CBX5 contains an N-terminal chromodomain that specifically binds trimethylated lysine 9 on histone H3 (H3K9me3), resulting in epigenetic repression and gene silencing[2][3]. The C-terminal chromoshadow domain mediates homodimerization and interaction with other chromatin-associated proteins, supporting the formation and maintenance of repressive chromatin domains and facilitating the assembly of heterochromatin at centromeres and telomeres[1][2][3][4]. CBX5 plays essential roles in genome stability, kinetochore and centromere function during cell division, and DNA damage response, and its dysregulation has been implicated in cancer and other diseases linked to chromatin dysfunction and genome instability[1][2][3]. Notes: - CBX5 itself is not commonly regarded as a classical therapeutic target (e.g., not a receptor, enzyme, transporter, or a routinely drugged protein), but its fundamental roles in epigenetic regulation and frequent upregulation in cancer make it a protein of high biological interest[1][2][3]. - No approved drugs currently directly target CBX5; manipulation of CBX5 or HP1α function is generally indirect, via modulation of histone methylation or chromatin states, which can have broad effects on chromatin and gene expression[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromobox protein homolog 5 (CBX5).